Ministry of Health and Family Welfare invites comments on its plan to re-classify ‘Oxytocin as a Schedule H1 category Drug’ till 17th August, 2018 by Lexplosion | Aug 13, 2018 | EHS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) proposes to omit oxytocin from the category... Read More
Retail Pharmacies will no longer sell Oxytocin, hospitals / clinics to contact Karnataka Antibiotics & Pharmaceuticals Ltd. for procuring by Lexplosion | Aug 9, 2018 | EHS, Healthcare, statesIn furtherance to the ban on manufacture for sale or distribution of Oxytocin by private... Read More
Ministry of Health and Family Welfare imposes ban on manufacturing of Oxytocin by private manufacturers effective 1.07.2018 by Lexplosion | Jul 11, 2018 | OPS, Pharmaceuticals, statesIn a Press Release dated 27th June, 2018, the Ministry of Health and Family Welfare has made the... Read More
Ministry of Health and Family Welfare notifies Drugs and Cosmetics (Fourth Amendment) Rules, 2018 by Lexplosion | Apr 26, 2018 | Healthcare, OPS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) has issued the Drugs and Cosmetics (Fourth... Read More
Ministry of Health and Family Welfare invites comments and objections to the draft Drugs and Cosmetics ( Amendment) Rules, 2018 by Lexplosion | Apr 17, 2018 | Healthcare, OPS, Pharmaceuticals, statesIn a recent notification dated April 12th, 2018, the Ministry of Health and Family Welfare... Read More
